Cargando…

Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists

This observational study explored the association between proton pump inhibitor (PPI) and histamine-2 receptor antagonist (H2RA) use and the risk of chronic kidney disease (CKD). Using the National Health Insurance Service-National Sample Cohort (NHIS-NSC) and six-hospital electronic health record (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kweon, Takhyeon, Kim, Yerim, Lee, Kyung Joo, Seo, Won-Woo, Seo, Seung In, Shin, Woon Geon, Shin, Dong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689439/ https://www.ncbi.nlm.nih.gov/pubmed/38036592 http://dx.doi.org/10.1038/s41598-023-48430-9

Ejemplares similares

Long-term use of proton-pump inhibitor on Alzheimer’s disease: a real-world distributed network analysis of six observational Korean databases using a Common Data Model
por: Kim, Yerim, et al.
Publicado: (2022)

Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study
por: Park, Jimyung, et al.
Publicado: (2022)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
por: Lee, Yong Kang, et al.
Publicado: (2023)

Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Song, Myung Jin, et al.
Publicado: (2021)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?
por: Tomita, Toshihiko, et al.
Publicado: (2011)

Comparison and Analysis of Delirium Induced by Histamine H(2) Receptor Antagonists and Proton Pump Inhibitors in Cancer Patients
por: Fujii, Shiro, et al.
Publicado: (2012)

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2012)

Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
por: Liu, Peipei, et al.
Publicado: (2020)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply
por: Nonaka, Takashi, et al.
Publicado: (2011)

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
por: Weiss, Karl, et al.
Publicado: (2015)

Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro
por: Lepczyńska, Małgorzata, et al.
Publicado: (2021)

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H(2) Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis
por: Gao, Jiamin, et al.
Publicado: (2022)

Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis
por: Azab, Mohamed, et al.
Publicado: (2017)

Prolonged Use of Proton Pump Inhibitors, but Not Histamine-2 Receptor Antagonists, Is Associated With Lower Bone Mineral Density in Males Aged Over 70
por: Gao, Shihua, et al.
Publicado: (2021)

Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs
por: Mottaghi, Batoul, et al.
Publicado: (2021)

Comparing the Safety and Efficacy of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in the Management of Patients With Peptic Ulcer Disease: A Systematic Review
por: Begg, Maha, et al.
Publicado: (2023)

Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B(12) Depletion
por: Zdilla, Matthew J.
Publicado: (2015)

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis
por: Kondo, Yutaka, et al.
Publicado: (2020)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
por: Jiang, Xin, et al.
Publicado: (2019)

Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?
por: De Benedetto, Anna, et al.
Publicado: (2015)

Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies
por: Wu, Chieh-Chen, et al.
Publicado: (2023)

Proton pump inhibitor: The dual role in gastric cancer
por: Joo, Moon Kyung, et al.
Publicado: (2019)

Exploration of Proton Pump Inhibitors Use During Pregnancy and Preeclampsia
por: Choi, Ahhyung, et al.
Publicado: (2021)

Effects of Proton Pump Inhibitors and H(2) Receptor Antagonists on the Ileum Motility
por: Kurt, Atilla, et al.
Publicado: (2011)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
por: Zhou, Xiaoyang, et al.
Publicado: (2019)

Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time (13)C Breath Test (BreathID System)
por: Nonaka, Takashi, et al.
Publicado: (2011)

Comparison of Proton Pump Inhibitor and Histamine-2 Receptor Antagonist in the Prevention of Recurrent Peptic Ulcers/Erosions in Long-Term Low-Dose Aspirin Users: A Retrospective Cohort Study
por: Chen, Wen-Chi, et al.
Publicado: (2014)

Influence of proton pump inhibitors and histamine H(2) receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review
por: Tatsuzawa, Masaomi, et al.
Publicado: (2016)

Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications
por: Shin, Cheol Min, et al.
Publicado: (2016)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications
por: Kishore, E, et al.
Publicado: (2023)

Synthesis of Gallic Acid Analogs as Histamine and Pro-Inflammatory Cytokine Inhibitors for Treatment of Mast Cell-Mediated Allergic Inflammation
por: Fei, Xiang, et al.
Publicado: (2017)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Histamine-2 receptor antagonists versus proton pump inhibitors for septic shock after lower gastrointestinal tract perforation: a retrospective cohort study using a national inpatient database
por: Suzuki, Jun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kl1cim26pb972vjqufvdod2qe4